NICE backing for Bayer’s Stivarga in GIST

12th October 2017 Uncategorised 0

Bayer’s Stivarga is being backed by the National Institute for Health and Care Excellence as a cost-effective option for the treatment of adults with gastrointestinal stromal tumours (GIST).

More: NICE backing for Bayer’s Stivarga in GIST
Source: News